RU EN KZ
Articles / Media / Article

Clinical Experience with the Use of Nanoiodine for Type 1 Diabetes

Clinical Experience with the Use of Nanoiodine for Type 1 Diabetes

Clinical Experience with the Use of Nanoiodine for Type 1 Diabetes

Clinical Experience with the Use of Nanoiodine for Type 1 Diabetes

Regarding Type 1 Diabetes

At present, we have only one solution available for people with Type 1 diabetes: taking nanoiodine for 1.5–2 years.

You can read the article providing the scientific rationale at the following link:

https://iod.kz/pages/article.php?id=17&lang=en&tab=articles&media_page=1&articles_page=1

Response from Academician Murat Turlubekov for People with Diabetes:

  1. When we say that this helps with diabetes, we rely on the following experiment: 15–20 individuals with very severe forms of Type 1 and Type 2 diabetes were selected and given nanoiodine for oral administration.
  2. The average duration of use was 1–2 years.
  3. Patients with Type 1 diabetes who were taking insulin recovered on average within 1 year, while patients with Type 2 diabetes recovered within 1.5–2 years.
  4. In addition, among these 15–20 individuals, nanoiodine did not affect 10%, while 90% recovered. In other words, out of 15–20 people, 2 patients did not recover. We had neither the time nor the resources to investigate the reasons for this. Official medicine and government institutions have not supported us and have never assisted. All of this work was carried out using our own funds.
  5. Therefore, based on the information available to us, we state that diabetes is cured in 90% of cases, while in 10% of cases it is not.
  6. Based on this information, by taking our product, you assume responsibility for the future outcome. We cannot provide any guarantees.
  7. We also sincerely wish you good health, prosperity, and a long life. Whatever treatment you choose, may Allah grant you a speedy recovery.